Acurx Pharmaceuticals (ACXP)
(Real Time Quote from BATS)
$4.32 USD
-0.23 (-5.06%)
Updated Oct 6, 2025 03:36 PM ET
2-Buy of 5 2
F Value B Growth F Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Acurx Pharmaceuticals, Inc. has a market cap of $7.21M, which represents its share price of $4.55 multiplied by its outstanding shares number of 1.58M. As a small-cap company, ACXP's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ACXP 4.32 -0.23(-5.06%)
Will ACXP be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for ACXP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACXP
Are Medical Stocks Lagging Acurx Pharmaceuticals (ACXP) This Year?
Waters Q1 Earnings Surpass Estimates, Revenue Rise Y/Y
ACXP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Acurx Pharmaceuticals (ACXP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know
Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?
Other News for ACXP
ACXP forms Boomer Buy Setup on October 3
ACXP forms Non-ADX 1,2,3,4 Bearish on October 2
Bollinger Band Squeeze appears for ACXP after 7.23% move
Is ACXP signaling a buying opportunity? 20 Day Moving Average Support shows up after climbing 0.23%
ACXP: HC Wainwright & Co. Reiterates Buy Rating with $31 Price Target | ACXP Stock News